TCWP’s Inari Medical, Inc. Common Stock NARI Stock Holding History

TCWP’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5	Closed	–	–	1841
2022 Q1	$0	Buy	+5	New	+$409	﹤0.01%	1936

Other funds holding NARI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

TCWP's NARI Position: Q2 2022 in Review

TCWP sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2022, closing a stake of 5 shares.

TCWP first reported a position in NARI in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 227 funds tracked by Wall St. Rank hold NARI as of Q2 2022.

TCWP reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
TCWP sold 5 Inari Medical, Inc. Common Stock shares in Q2 2022.
TCWP first reported a position in Inari Medical, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
TCWP's Inari Medical, Inc. Common Stock position peaked at $0 in Q1 2022.
227 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.